Does Perseris Cause Weight Gain?
Perseris, an extended-release risperidone injection for schizophrenia, lists weight gain as a common side effect. Clinical trials showed 21% of patients gained at least 7% of their baseline body weight, compared to 11% on placebo.[1][2] The prescribing information notes this risk stems from risperidone's effects on appetite and metabolism, with monitoring recommended.[3]
How Common Is Weight Gain on Perseris?
In the pivotal Phase 3 trial (n=365), mean weight increase was 2.2 kg over 13 weeks, versus 0.6 kg for placebo. By 48 weeks in long-term data, average gain reached 4.9 kg.[1] Rates vary by patient factors like age, sex, and baseline BMI—younger adults and those with higher starting weights saw more pronounced gains.[2]
Why Does Perseris Lead to Weight Gain?
Risperidone, Perseris's active ingredient, blocks histamine and serotonin receptors, boosting appetite and altering fat storage. Unlike oral forms, Perseris's subcutaneous depot delivery maintains steady levels, potentially amplifying metabolic shifts over time.[3][4] Antipsychotic class effects contribute, with risperidone ranking moderate for weight impact versus high-risk options like olanzapine.[5]
How Does Perseris Compare to Other Antipsychotics for Weight Gain?
| Drug | Mean Weight Gain (Short-Term Trials) | % Patients ≥7% Gain |
|------|--------------------------------------|---------------------|
| Perseris (risperidone ER) | 2.2 kg (13 weeks) [1] | 21% [2] |
| Oral Risperidone | 1.5-2.0 kg [5] | 18-20% [5] |
| Invega Sustenna (paliperidone) | 1.0 kg [6] | 9% [6] |
| Abilify Maintena (aripiprazole) | 0.5 kg [6] | 6% [6] |
| Zyprexa Relprevv (olanzapine) | 4.0+ kg [5] | 30%+ [5] |
Perseris aligns with oral risperidone but exceeds lower-risk depot options like aripiprazole.[5][6]
What Can Patients Do About Weight Gain?
Lifestyle interventions—diet tracking, exercise, and caloric restriction—reduced gains in adjunct studies.[4] Switching to lower-risk antipsychotics like aripiprazole may help, though relapse risk exists. Providers often prescribe metformin off-label for mitigation, with evidence of 2-3 kg prevention in antipsychotic users.[7] Regular weigh-ins are standard.
When Does Weight Gain Typically Start?
Most gains occur within the first 3-6 months, peaking around 1 year before stabilizing. Early intervention curbs progression.[1][3]
[1]: Perseris Prescribing Information (Indivior, 2023)
[2]: NCT02120365 Trial Results (ClinicalTrials.gov)
[3]: FDA Label for Perseris
[4]: J Clin Psychiatry: Risperidone Depot Weight Effects (2019)
[5]: Lancet Psychiatry: Antipsychotic Weight Gain Meta-Analysis (2019)
[6]: Invega Sustenna vs. Perseris Comparative Data (Janssen/Indivior)
[7]: Am J Psychiatry: Metformin for Antipsychotic Weight Gain (2013)